• Brain-to-Spinal Circuits Regulate Mechanical Allodynia Later

  2026-06-02

  Huo et al. (2023) identify specific contralateral brain-to-spinal pathways that determine both the side-specificity and persistence of mechanical allodynia in mice. The study delineates a descending circuit involving hypothalamic dynorphin and spinal κ-opioid receptor signaling, offering new mechanistic insight for pain modulation research.

• LY-411575 (A4019): Reliable Gamma-Secretase Inhibition for C

  2026-06-01

  This article provides scenario-driven, evidence-based guidance for biomedical researchers using LY-411575 (SKU A4019) in cell viability, proliferation, and cytotoxicity assays. We address common lab challenges, highlight quantitative performance metrics, and offer practical protocol recommendations for leveraging this potent gamma-secretase inhibitor from APExBIO.

• TMRE Mitochondrial Membrane Potential Assay Kit: Precision i

  2026-06-01

  Explore how the TMRE mitochondrial membrane potential assay kit empowers advanced mitochondrial function analysis, particularly in the context of sodium-induced energy failure. This in-depth guide offers unique protocol insights and decision-making strategies for accurate cell apoptosis detection.

• CDK9 Inhibitor (A3294): Technical Guidance and Protocol Para

  2026-05-31

  The CDK9 inhibitor (SKU A3294) addresses the need for selective, non-cytotoxic inhibition of cyclin dependent kinase 9 in studies of transcription elongation, HIV-1 propagation, and related regulatory mechanisms. It is not suitable for protocols requiring broad-spectrum CDK inhibition or long-term storage of prepared solutions, and should be handled according to specific solubility and storage guidelines to ensure reproducibility.

• Translating Apoptosis Insight: Strategic Use of TUNEL Cy3 Ki

  2026-05-30

  Explore the intersection of mechanistic apoptosis research and translational innovation in liver injury models. This article unpacks the clinical and experimental stakes of precise apoptosis detection, highlights the unique capabilities of the One-step TUNEL Cy3 Apoptosis Detection Kit, and delivers actionable guidance for researchers aiming to bridge discovery and therapeutic impact. Anchored by recent advances in peptidomics and hepatoprotective strategies, this piece positions APExBIO’s kit as central to next-generation apoptosis quantification—going beyond standard product overviews and equipping scientists to drive reproducible, high-impact translational studies.

• BicD and MAP7 Synergistically Activate Drosophila Kinesin-1

  2026-05-29

  This study elucidates how adaptor protein BicD and microtubule-associated protein MAP7 distinctly and cooperatively relieve auto-inhibition of homodimeric Drosophila kinesin-1. The findings advance mechanistic understanding of bidirectional cargo transport regulation and have practical implications for reconstructing motor protein complexes in vitro.

• Dinaciclib (SCH727965): Advancing Tissue Boundary and Cancer

  2026-05-29

  Dinaciclib (SCH727965) offers precision CDK inhibition for dissecting cell cycle, apoptosis, and tissue boundary dynamics in cancer and developmental systems. This guide translates breakthrough mechanobiology findings into actionable experimental workflows and troubleshooting strategies, equipping researchers to bridge cell cycle control with tissue compartmentalization.

• Mubritinib (TAK 165): Advanced Protocols in AML and PEL Rese

  2026-05-28

  Mubritinib (TAK 165) is redefining targeted cancer and viral oncology research by selectively inhibiting mitochondrial complex I. This guide details experimental workflows, troubleshooting strategies, and innovative use-cases for maximizing the compound's translational potential in acute myeloid leukemia and primary effusion lymphoma studies.

• Estradiol in Research: Protocols and Organ Protection Insigh

  2026-05-28

  Estradiol offers a robust platform for modeling estrogen receptor signaling and autophagy-mediated organ protection, with validated workflows that bridge population and animal studies. This guide details high-impact experimental strategies, highlights reference study findings, and provides troubleshooting solutions for multi-organ protection assays using APExBIO's Estradiol.

• Annexin V-PE Reagent: Precision Workflows for Apoptotic Cell

  2026-05-27

  Annexin V-PE Reagent combines rapid, one-step apoptosis detection with robust phosphatidylserine binding, empowering high-throughput and high-selectivity cell death assays. This article details optimized workflows, troubleshooting strategies, and translational advantages, linking cutting-edge CAR-T research insights to practical laboratory implementation.

• Aminocoumarin Probe Illuminates HO-1 Regulation in Live Macr

  2026-05-27

  This study introduces a red-shifted aminocoumarin-based fluorescent probe (AMC-Hem) for real-time measurement and visualization of heme oxygenase-1 (HO-1) activity in live human macrophages. The probe enabled novel insights into HO-1's subcellular localization, non-transcriptional regulation, and translational potential for vascular disease research.

• SB 431542: Advanced ALK5 Inhibitor Workflows for TGF-β Resea

  2026-05-26

  SB 431542 is a gold-standard ALK5 inhibitor that empowers researchers to dissect TGF-β signaling in disease and regeneration models. This guide unpacks experimental workflows, troubleshooting, and the latest reference innovations, with actionable protocol parameters for maximal reproducibility.

• D-N-Acetylgalactosamine: Technical Guide for Glycoprotein An

  2026-05-26

  D-N-Acetylgalactosamine is a high-purity, water-soluble standard designed for accurate investigation of glycoprotein constituents and glycosylation pathways in neurological research. It is unsuitable for ethanol-based workflows or protocols requiring long-term storage of prepared solutions, making strict protocol adherence critical for reproducible data.

• Mubritinib (TAK 165): Transforming OXPHOS Targeting in Cance

  2026-05-25

  This article dissects Mubritinib’s mitochondrial complex I inhibition, its repurposing for chemotherapy-resistant AML and KSHV-driven primary effusion lymphoma, and provides actionable protocol guidance for translational researchers. By connecting mechanistic insight, literature-backed validation, and strategic workflow advice, we frame Mubritinib (TAK 165) as a next-generation tool for dissecting metabolic vulnerabilities in cancer.

• Cell Cycle Assay Kit (K2263): Deeper Insights for Epigenetic

  2026-05-25

  Discover how the Cell Cycle Assay Kit enables precise analysis of cell cycle phases and apoptosis, with a focus on epigenetic mechanisms and translational cancer research. This article explores advanced applications and protocol nuances for researchers seeking more than routine cell cycle progression analysis.

450 records 16/30 page Previous Next First page 上5页 1617181920 下5页 Last page